Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-04-27
1985-08-27
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 83, 546 84, 546164, A61K 3147, C07D51302
Patent
active
045378932
ABSTRACT:
Trans-(.+-.) 2 and/or 5-permissibly substituted octahydrothiazolo[4,5-g]quinolines and acid addition or quaternary salts thereof and, individual enantiomers thereof, useful as dopamine agonists.
REFERENCES:
patent: 3714170 (1973-01-01), Dohmori et al.
patent: 4258049 (1981-03-01), Bondinell et al.
patent: 4367231 (1983-01-01), Kornfeld et al.
Fujita et al., J. Pharm. Soc. Japan, 76, 817-820, (1956).
Kornfeld Edmund C.
Titus Robert D.
Bucci Ann
Eli Lilly and Company
Jiles Henry R.
Rowe James L.
Whale Arthur R.
LandOfFree
Octahydrothiazolo[4,5-g]quinolines and use as prolactin secretio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Octahydrothiazolo[4,5-g]quinolines and use as prolactin secretio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Octahydrothiazolo[4,5-g]quinolines and use as prolactin secretio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2001872